Ouro Fino Participações E Empreendimentos S A Y Universidade De São Paulo – Usp
Univ São Paulo – Usp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ouro Fino Participações E Empreendimentos S A Y Universidade De São Paulo – Usp, Univ São Paulo – UspfiledCriticalOuro Fino Participações E Empreendimentos S A Y Universidade De São Paulo – Usp
Priority to UY0001035730ApriorityCriticalpatent/UY35730A/en
Publication of UY35730ApublicationCriticalpatent/UY35730A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
La presente invención trata de composiciones farmacéuticas, comprendiendo un péptido estimulador de la liberación de gonadotropinas y esteroides sexuales. Más específicamente, la presente invención propone composiciones farmacéuticas comprendiendo kisspeptin, preferentemente, la forma kp-10 o derivados, para el uso en programas de inducción de ciclicidad y/o tratamiento de infertilidad. Las formulaciones de la presente invención están comprendidas en dos grupos principales: soluciones inyectables 1 y 0 formulaciones implantables.The present invention relates to pharmaceutical compositions, comprising a peptide stimulating the release of gonadotropins and sex steroids. More specifically, the present invention proposes pharmaceutical compositions comprising kisspeptin, preferably, the kp-10 form or derivatives, for use in induction programs of cyclicity and / or infertility treatment. The formulations of the present invention fall into two main groups: injectable solutions 1 and 0 implantable formulations.
UY0001035730A2014-09-092014-09-09
PHARMACEUTICAL COMPOSITIONS UNDERSTANDING KISSPEPTIN OR ITS DERIVATIVES
UY35730A
(en)
Compounds derived from 2-oxy-2-phenyl-n-5-pyrrolidin-3-ylamino-1,3,4-thiadiazol-2-ylacetamide, pharmaceutical composition gls1 inhibitors and their use to treat cancer.
Compounds derived from 2-8-5-chloropyrimidin-2-ylamino-6,7,8,9-tetrahydro-5h-pyrido3,2-bindol-5-ylacetic acid, modulators of the prostaglandin d2 receptor pharmaceutical composition and its use for the treatment of diseases allergic immune disorders.